High Prevalence and Significance of Hepatitis D Virus Infection among Treatment-Naïve HBsAg-Positive Patients in Northern Vietnam

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Sy, Bui Tien ^a,b   Ratsch, Boris A ^a   Toan, Nguyen Linh ^b   Song, Le Huu ^c   Wollboldt, Christian ^a   Bryniok, Agnes ^a   Nguyen, Hung Minh ^d   Van Luong, Hoang ^b   Velavan, Thirumalaisamy P ^e   Wedemeyer, Heiner ^f   Kremsner, Peter G ^e   Bock, C Thomas ^a,e  

^a ROBERT KOCH INSTITUTE   (Germany)

^b VIETNAM MILITARY MEDICAL UNIVERSITY   (Viet Nam)

^c Tran Hung Dao Hospital   (Viet Nam)

^d DUY TAN UNIVERSITY   (Viet Nam)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEPATITIS B SURFACE ANTIGEN;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASIAN; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DELTA AGENT HEPATITIS; ETHNIC GROUP; FEMALE; GENE CLUSTER; GENE SEQUENCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; PHYLOGENY; PREVALENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; VIET NAM; VIETNAMESE; VIRUS GENOME; VIRUS LOAD; VIRUS REPLICATION;

ADOLESCENT; ADULT; AGED; BILIRUBIN; FEMALE; GENOTYPE; HEPATITIS B SURFACE ANTIGENS; HEPATITIS D; HEPATITIS DELTA VIRUS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIETNAM; YOUNG ADULT;

EID: 84885704621     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078094     Document Type: Article

References (55)

1. Romeo R, Del Ninno E, Rumi M, Russo A, Sangiovanni A, et al. (2009) A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology 136: 1629-1638. doi:10.1053/j.gastro.2009.01.052. PubMed: 19208358.
2. Niro GA, Smedile A, Ippolito AM, Ciancio A, Fontana R, et al. (2010) Outcome of chronic delta hepatitis in Italy: a long-term cohort study. J Hepatol 53: 834-840. doi:10.1016/j.jhep.2010.06.008. PubMed: 20800919.
3. Rizzetto M, (2009) Hepatitis D: thirty years after. J Hepatol 50: 1043-1050. doi:10.1016/j.jhep.2009.01.004. PubMed: 19285743.
4. Taylor JM, (2012) Virology of hepatitis D virus. Semin Liver Dis 32: 195-200. doi:10.1055/s-0032-1323623. PubMed: 22932967.
5. Taylor JM, (2006) Hepatitis delta virus. Virology 344: 71-76. doi:10.1016/j.virol.2005.09.033. PubMed: 16364738.
6. Hughes SA, Wedemeyer H, Harrison PM, (2011) Hepatitis delta virus. Lancet 378: 73-85. doi:10.1016/S0140-6736(10)61931-9. PubMed: 21511329.
7. Taylor JM, (2009) Replication of the hepatitis delta virus RNA genome chapter 3. Adv Virus Res 74: 103-121 doi:10.1016/S0065-3527(09)74003-5. PubMed: 19698896.
8. Le Gal F, Gault E, Ripault MP, Serpaggi J, Trinchet JC, et al. (2006) Eighth major clade for hepatitis delta virus. Emerg Infect Dis 12: 1447-1450. doi:10.3201/eid1209.060112. PubMed: 17073101.
9. Barros LM, Gomes-Gouvêa MS, Pinho JR, Alvarado-Mora MV, Dos Santos A, et al. (2011) Hepatitis Delta virus genotype 8 infection in Northeast Brazil: inheritance from African slaves? Virus Res 160: 333-339. doi:10.1016/j.virusres.2011.07.006. PubMed: 21798297.
10. Wedemeyer H, Manns MP, (2010) Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat. Rev Gastroenterol Hepatol 7: 31-40. doi:10.1038/nrgastro.2009.205.
11. Wu JC, Chen CM, Sheen IJ, Lee SD, Tzeng HM, et al. (1995) Evidence of transmission of hepatitis D virus to spouses from sequence analysis of the viral genome. Hepatology 22: 1656-1660. doi:10.1002/hep.1840220607. PubMed: 7489970.
12. Imazeki F, Omata M, Ohto M, (1990) Heterogeneity and evolution rates of delta virus RNA sequences. J Virol 64: 5594-5599. PubMed: 2214027.
13. Ivaniushina V, Radjef N, Alexeeva M, Gault E, Semenov S, et al. (2001) Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia. J Gen Virol 82: 2709-2718. PubMed: 11602783.
14. Alvarado-Mora MV, Romano CM, Gomes-Gouvêa MS, Gutierrez MF, Carrilho FJ, et al. (2011) Dynamics of hepatitis D (delta) virus genotype 3 in the Amazon region of South America. Infect Genet Evol 11: 1462-1468. doi:10.1016/j.meegid.2011.05.020. PubMed: 21645647.
15. Lu SN, Chen TM, Lee CM, Wang JH, Tung HD, et al. (2003) Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. J Med Virol 70: 74-80. doi:10.1002/jmv.10361. PubMed: 12629646.
16. Sakugawa H, Nakasone H, Nakayoshi T, Kawakami Y, Miyazato S, et al. (1999) Hepatitis delta virus genotype IIb predominates in an endemic area, Okinawa, Japan. J Med Virol 58: 366-372. doi:10.1002/(SICI)1096-9071(199908)58:4. PubMed: 10421403.
17. Watanabe H, Nagayama K, Enomoto N, Chinzei R, Yamashiro T, et al. (2003) Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease. J Gen Virol 84: 3275-3289. doi:10.1099/vir.0.19499-0. PubMed: 14645909.
18. Hsu SC, Syu WJ, Sheen IJ, Liu HT, Jeng KS, et al. (2002) Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications. Hepatology 35: 665-672. doi:10.1053/jhep.2002.31777. PubMed: 11870382.
19. Gomes-Gouvêa MS, Soares MC, Bensabath G, de Carvalho-Mello IM, Brito EM, et al. (2009) Hepatitis B virus and hepatitis delta virus genotypes in outbreaks of fulminant hepatitis (Labrea black fever) in the western Brazilian Amazon region. J Gen Virol 90: 2638-2643. doi:10.1099/vir.0.013615-0. PubMed: 19605587.
20. Wu JC, (2006) Functional and clinical significance of hepatitis D virus genotype II infection. Curr Top Microbiol Immunol 307: 173-186. doi:10.1007/3-540-29802-9_9. PubMed: 16903226.
21. Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloǧlu Y, et al. (2011) Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med 364: 322-331. doi:10.1056/NEJMoa0912696. PubMed: 21268724.
22. Babiker ZO, Hogan C, Ustianowski A, Wilkins E, (2012) Does interferon-sparing tenofovir disoproxil fumarate-based therapy have a role in the management of severe acute hepatitis delta superinfection? J Med Microbiol 61: 1780-1783. doi:10.1099/jmm.0.046649-0. PubMed: 22956751.
23. Rizzetto M, (2013) Current management of delta hepatitis. Liver Int 33 (Suppl 1):: 195-197. doi:10.1111/liv.12058. PubMed: 23286865.
24. Wedemeyer H, (2011) Hepatitis D revival. Liver Int 31 (Suppl 1):: 140-144. doi:10.1111/j.1478-3231.2010.02334.x. PubMed: 21205152.
25. Kabaçam G, Onder FO, Yakut M, Seven G, Karatayli SC, et al. (2012) Entecavir treatment of chronic hepatitis D. Clin Infect Dis 55: 645-650. doi:10.1093/cid/cis459. PubMed: 22573857.
26. Gaeta GB, Stroffolini T, Chiaramonte M, Ascione T, Stornaiuolo G, et al. (2000) Chronic hepatitis D: a vanishing Disease? An Italian multicenter study. Hepatology 32: 824-827. doi:10.1053/jhep.2000.17711. PubMed: 11003629.
27. Huo TI, Wu JC, Lin RY, Sheng WY, Chang FY, et al. (1997) Decreasing hepatitis D virus infection in Taiwan: an analysis of contributory factors. J Gastroenterol Hepatol 12: 747-751. doi:10.1111/j.1440-1746.1997.tb00364.x. PubMed: 9430041.
28. Navascués CA, Rodríguez M, Sotorrío NG, Sala P, Linares A, et al. (1995) Epidemiology of hepatitis D virus infection: changes in the last 14 years. Am J Gastroenterol 90: 1981-1984. PubMed: 7485005.
29. Dunford L, Carr MJ, Dean J, Nguyen LT, Ta Thi TH, et al. (2012) A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam. PLOS ONE 7: e39027. doi:10.1371/journal.pone.0039027. PubMed: 22720022.
30. Gish RG, Bui TD, Nguyen CT, Nguyen DT, Tran HV, et al. (2012) Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action. J Gastroenterol Hepatol 27: 238-247. doi:10.1111/j.1440-1746.2011.06974.x. PubMed: 22098550.
31. Nguyen VT, Law MG, Dore GJ, (2008) An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int 28: 525-531. doi:10.1111/j.1478-3231.2007.01646.x. PubMed: 18266635.
32. Nguyen VT, McLaws ML, Dore GJ, (2007) Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol 22: 2093-2100. doi:10.1111/j.1440-1746.2007.05010.x. PubMed: 17645465.
33. Tran HT, Ushijima H, Quang VX, Phuong N, Li TC, et al. (2003) Prevalence of hepatitis virus types B through E and genotypic distribution of HBV and HCV in Ho Chi Minh City, Vietnam. Hepatol Res 26: 275-280. doi:10.1016/S1386-6346(03)00166-9. PubMed: 12963426.
34. Duraisamy G, Zuridah H, Ariffin Y, Kek CS, (1994) Hepatitis delta virus in intravenous drug users in Kuala Lumpur. Med J Malays 49: 212-216. PubMed: 7845268.
35. Theamboonlers A, Hansurabhanon T, Verachai V, Chongsrisawat V, Poovorawan Y, (2002) Hepatitis D virus infection in Thailand: HDV genotyping by RT-PCR, RFLP and direct sequencing. Infection 30: 140-144. doi:10.1007/s15010-002-2061-x. PubMed: 12120938.
36. Song le H, Binh VQ, Duy DN, Kun JF, Bock TC, et al. (2003) Serum cytokine profiles associated with clinical presentation in Vietnamese infected with hepatitis B virus. J Clin Virol 28: 93-103. doi:10.1016/S1386-6532(02)00271-8. PubMed: 12927756.
37. Song le H, Binh VQ, Duy DN, Bock TC, Kremsner PG, et al. (2004) Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus. J Med Virol 73: 244-249. doi:10.1002/jmv.20082. PubMed: 15122799.
38. Mederacke I, Bremer B, Heidrich B, Kirschner J, Deterding K, et al. (2010) Establishment of a novel quantitative hepatitis D virus (HDV) RNA assay using the Cobas TaqMan platform to study HDV RNA kinetics. J Clin Microbiol 48: 2022-2029. doi:10.1128/JCM.00084-10. PubMed: 20351206.
39. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, et al. (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28: 2731-2739. doi:10.1093/molbev/msr121. PubMed: 21546353.
40. Stroffolini T, Almasio PL, Sagnelli E, Mele A, Gaeta GB, et al. (2009) Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study. J Med Virol 81: 1999-2006. doi:10.1002/jmv.21643. PubMed: 19856477.
41. Wedemeyer H, Heidrich B, Manns MP, (2007) Hepatitis D virus infection--not a vanishing disease in Europe! Hepatology 45: 1331-1333; author reply: 17464980.
42. Cross TJ, Rizzi P, Horner M, Jolly A, Hussain MJ, et al. (2008) The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol 80: 277-282. doi:10.1002/jmv.21078. PubMed: 18098143.
43. Popescu GA, Otelea D, Gavriliu LC, Neaga E, Popescu C, et al. (2013) Epidemiology of hepatitis D in patients infected with hepatitis B virus in bucharest: A cross-sectional study. J Med Virol 85: 769-774. doi:10.1002/jmv.23524. PubMed: 23408537.
44. Mumtaz K, Ahmed US, Memon S, Khawaja A, Usmani MT, et al. (2011) Virological and clinical characteristics of hepatitis delta virus in South Asia. Virol J 8: 312. doi:10.1186/1743-422X-8-312. PubMed: 21689416.
45. Davaalkham D, Ojima T, Uehara R, Watanabe M, Oki I, et al. (2006) Hepatitis delta virus infection in mongolia: analyses of geographic distribution, risk factors, and disease severity. Am J Trop Med Hyg 75: 365-369. PubMed: 16896150.
46. Ciancio A, Rizzetto M, (2002) Clinical patterns, epidemiology and disease burden of hepatitis D virus chronic liver disease. 10th International Symposium on Viral Hepatitis and Liver Disease: London. International Medical Press. pp. 271-275.
47. Kim HS, Kim SJ, Park HW, Shin WG, Kim KH, et al. (2011) Prevalence and clinical significance of hepatitis D virus co-infection in patients with chronic hepatitis B in Korea. J Med Virol 83: 1172-1177. doi:10.1002/jmv.22095. PubMed: 21541950.
48. Tan DS, Dimitrakakis M, Mangalam S, Lopez CG, Ooi BG, (1989) Prevalence of hepatitis delta virus infection in Malaysia. Singapore Med J 30: 34-37. PubMed: 2595386.
49. Lusida MI, Surayah, Sakugawa H, Nagano-Fujii M, Soetjipto et al,. (2003) Genotype and subtype analyses of hepatitis B virus (HBV) and possible co-infection of HBV and hepatitis C virus (HCV) or hepatitis D virus (HDV) in blood donors, patients with chronic liver disease and patients on hemodialysis in Surabaya, Indonesia. Microbiol Immunol 47: 969-975. PubMed: 14695447.
50. Brichler S, Le Gal F, Butt A, Chevret S, Gordien E, (2013) Commercial Real-Time Reverse Transcriptase PCR Assays Can Underestimate or Fail to Quantify Hepatitis D Virus Viremia. Clin Gastroenterol Hepatol 11: 734-740. doi:10.1016/j.cgh.2013.01.025. PubMed: 23376798.
51. Casey JL, Niro GA, Engle RE, Vega A, Gomez H, et al. (1996) Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. J Infect Dis 174: 920-926. doi:10.1093/infdis/174.5.920. PubMed: 8896491.
52. Flodgren E, Bengtsson S, Knutsson M, Strebkova EA, Kidd AH, et al. (2000) Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol 38: 3311-3316. PubMed: 10970376.
53. Pascarella S, Negro F, (2011) Hepatitis D virus: an update. Liver Int 31: 7-21. doi:10.1111/j.1478-3231.2010.02320.x. PubMed: 20880077.
54. Pollicino T, Raffa G, Santantonio T, Gaeta GB, Iannello G, et al. (2011) Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. J Virol 85: 432-439. doi:10.1128/JVI.01609-10. PubMed: 20962099.
55. Toan NL, Song le H, Kremsner PG, Duy DN, Binh VQ, et al. (2006) Impact of the hepatitis B virus genotype and genotype mixtures on the course of liver disease in Vietnam. Hepatology 43: 1375-1384. doi:10.1002/hep.21188. PubMed: 16729315.